Literature DB >> 16082529

Association between polymorphisms in the nuclear respiratory factor 1 gene and type 2 diabetes mellitus in the Korean population.

Y M Cho1, H D Shin, B L Park, J H Kim, K S Park, S Y Kim, H K Lee.   

Abstract

AIMS/HYPOTHESIS: Dysfunction in mitochondrial oxidative phosphorylation plays a central role in insulin resistance and type 2 diabetes. Nuclear respiratory factor 1 (NRF1) is a transcription factor that acts on nuclear genes encoding respiratory subunits and components of the mitochondrial transcription and replication machinery. Thus, we investigated its genetic association with type 2 diabetes.
METHODS: The NRF1 gene was sequenced to identify polymorphisms in 24 Korean DNA samples and then common variants were genotyped in 766 patients with type 2 diabetes and 303 non-diabetic subjects.
RESULTS: Twelve single nucleotide polymorphisms and one insertion/deletion polymorphism were identified. Six common variants among them were genotyped in a larger study. Although three individual polymorphisms appeared to be associated with type 2 diabetes (g.-46350insdel A, g.+141G>T and g.+54529A>G), the effects were only marginal. However, a haplotype (H2) was associated with a decreased risk of type 2 diabetes and another haplotype (H4) was associated with an increased risk of type 2 diabetes (p values for the Haplo. Score test were 0.009 and 0.004, respectively). CONCLUSIONS/
INTERPRETATION: We demonstrated that two common haplotypes of NRF1 gene are associated with type 2 diabetes in the Korean population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082529     DOI: 10.1007/s00125-005-1855-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  An analysis of strategies for discovery of single-nucleotide polymorphisms.

Authors:  M A Eberle; L Kruglyak
Journal:  Genet Epidemiol       Date:  2000       Impact factor: 2.135

Review 2.  Crosstalk between nuclear and mitochondrial genomes.

Authors:  R O Poyton; J E McEwen
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

Review 3.  Genetic determinants of type 2 diabetes.

Authors:  P Froguel; G Velho
Journal:  Recent Prog Horm Res       Date:  2001

4.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.

Authors:  M D Ritchie; L W Hahn; N Roodi; L R Bailey; W D Dupont; F F Parl; J H Moore
Journal:  Am J Hum Genet       Date:  2001-06-11       Impact factor: 11.025

Review 5.  The genetics of type 2 diabetes.

Authors:  A L Gloyn; M I McCarthy
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2001-09       Impact factor: 4.690

6.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

Authors:  K Quandt; K Frech; H Karas; E Wingender; T Werner
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

7.  NRF-1: a trans-activator of nuclear-encoded respiratory genes in animal cells.

Authors:  M J Evans; R C Scarpulla
Journal:  Genes Dev       Date:  1990-06       Impact factor: 11.361

8.  Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. Characterization of upstream NRF-1, ATF, and intron Sp1 recognition sequences.

Authors:  M J Evans; R C Scarpulla
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

9.  Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus.

Authors:  Y M Cho; M D Ritchie; J H Moore; J Y Park; K-U Lee; H D Shin; H K Lee; K S Park
Journal:  Diabetologia       Date:  2004-01-17       Impact factor: 10.122

10.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

View more
  7 in total

1.  Transcriptional regulation of insulin-degrading enzyme modulates mitochondrial amyloid β (Aβ) peptide catabolism and functionality.

Authors:  María C Leal; Natalia Magnani; Sergio Villordo; Cristina Marino Buslje; Pablo Evelson; Eduardo M Castaño; Laura Morelli
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

2.  Nuclear respiratory factor 1 mediates the transcription initiation of insulin-degrading enzyme in a TATA box-binding protein-independent manner.

Authors:  Lang Zhang; Qingyang Ding; Zhao Wang
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

3.  The search for genetic risk factors of type 2 diabetes mellitus.

Authors:  Kyong Soo Park
Journal:  Diabetes Metab J       Date:  2011-02-28       Impact factor: 5.376

4.  Gene expression pattern in transmitochondrial cytoplasmic hybrid cells harboring type 2 diabetes-associated mitochondrial DNA haplogroups.

Authors:  Seungwoo Hwang; Soo Heon Kwak; Jong Bhak; Hae Sun Kang; You Ri Lee; Bo Kyung Koo; Kyong Soo Park; Hong Kyu Lee; Young Min Cho
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

Review 5.  Mitochondrial regulation of β-cell function: maintaining the momentum for insulin release.

Authors:  Brett A Kaufman; Changhong Li; Scott A Soleimanpour
Journal:  Mol Aspects Med       Date:  2015-02-07

6.  Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats.

Authors:  Wenjuan Liu; Wei Gong; Min He; Yemei Liu; Yeping Yang; Meng Wang; Meng Wu; Shizhe Guo; Yifei Yu; Xuanchun Wang; Fei Sun; Yiming Li; Linuo Zhou; Shengmei Qin; Zhaoyun Zhang
Journal:  J Diabetes Res       Date:  2018-10-14       Impact factor: 4.011

7.  Pseudoautosomal Region 1 Overdosage Affects the Global Transcriptome in iPSCs From Patients With Klinefelter Syndrome and High-Grade X Chromosome Aneuploidies.

Authors:  Veronica Astro; Maryam Alowaysi; Elisabetta Fiacco; Alfonso Saera-Vila; Kelly J Cardona-Londoño; Riccardo Aiese Cigliano; Antonio Adamo
Journal:  Front Cell Dev Biol       Date:  2022-02-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.